Abstract
Background and Aims: Loss of function mutations in ANGPTL3 cause low plasma lipid concentrations. Statins supposedly suppress hepatic ANGPTL3 mRNA expression in healthy subjects (J. Intern. Med. 2011: 269: 333). How statins regulate Angptl3 and whether statins reduce plasma Angptl3 concentrations in patients with elevated LDL cholesterol levels, e.g., familial hypercholesterolemia (FH), is unknown.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
